Zangdong He

2.4k total citations
23 papers, 637 citations indexed

About

Zangdong He is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Zangdong He has authored 23 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Hematology and 4 papers in Oncology. Recurrent topics in Zangdong He's work include Multiple Myeloma Research and Treatments (7 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Statistical Methods and Inference (3 papers). Zangdong He is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Statistical Methods and Inference (3 papers). Zangdong He collaborates with scholars based in United States, China and United Kingdom. Zangdong He's co-authors include Adam D. Cohen, Paul G. Richardson, Rakesh Popat, Suzanne Trudel, Nikoletta Lendvai, Peter M. Voorhees, Joanna Opalinska, Axel Hoos, Brandi Reeves and Edward N. Libby and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Lancet Oncology.

In The Last Decade

Zangdong He

22 papers receiving 632 citations

Peers

Zangdong He
Shipra Gandhi United States
Lu Zhao China
Colin D. Godwin United States
Matts Kågedal Sweden
Shikiko Watanabe Belgium
Rosa Di Bitondo Italy
A. Prechtl Germany
David Ladkani Israel
Martina Urbanek Austria
Kevin Brady United Kingdom
Shipra Gandhi United States
Zangdong He
Citations per year, relative to Zangdong He Zangdong He (= 1×) peers Shipra Gandhi

Countries citing papers authored by Zangdong He

Since Specialization
Citations

This map shows the geographic impact of Zangdong He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zangdong He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zangdong He more than expected).

Fields of papers citing papers by Zangdong He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zangdong He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zangdong He. The network helps show where Zangdong He may publish in the future.

Co-authorship network of co-authors of Zangdong He

This figure shows the co-authorship network connecting the top 25 collaborators of Zangdong He. A scholar is included among the top collaborators of Zangdong He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zangdong He. Zangdong He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Popat, Rakesh, Sagar Lonial, Peter M. Voorhees, et al.. (2023). Patient-Reported Outcomes With Belantamab Mafodotin Treatment in Patients With Triple-Class Refractory Multiple Myeloma. Journal of the Advanced Practitioner in Oncology. 14(6). 503–518. 3 indexed citations
3.
Popat, Rakesh, Sagar Lonial, Peter M. Voorhees, et al.. (2020). DREAMM-2: Single-Agent Belantamab Mafodotin (Belamaf) Effects on Patient-Reported Outcome (PRO) Measures in Patients with Relapsed/Refractory Multiple Myeloma (RRMM). Blood. 136(Supplement 1). 27–28. 6 indexed citations
4.
Bandyopadhyay, Deepak, Constantine Kreatsoulas, J. Gregory Boyer, et al.. (2019). Scaffold-Based Analytics: Enabling Hit-to-Lead Decisions by Visualizing Chemical Series Linked across Large Datasets. Journal of Chemical Information and Modeling. 59(11). 4880–4892. 6 indexed citations
5.
Trudel, Suzanne, Nikoletta Lendvai, Rakesh Popat, et al.. (2019). Antibody–drug conjugate, GSK2857916, in relapsed/refractory multiple myeloma: an update on safety and efficacy from dose expansion phase I study. Blood Cancer Journal. 9(4). 37–37. 171 indexed citations
6.
Xie, Yujing, et al.. (2019). Variable selection for joint models with time-varying coefficients. Statistical Methods in Medical Research. 29(1). 309–322. 5 indexed citations
7.
Trudel, Suzanne, Nikoletta Lendvai, Rakesh Popat, et al.. (2018). Targeting B-cell maturation antigen with GSK2857916 antibody–drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial. The Lancet Oncology. 19(12). 1641–1653. 192 indexed citations
8.
Dettman, Elisha J., Fabio Rigat, Mary Birchler, et al.. (2018). Expression of Myeloma Cell and Soluble B-Cell Maturation Antigen (BCMA) in Relapsed and Refractory Multiple Myeloma Patients Treated with GSK2857916 in BMA117159. Blood. 132(Supplement 1). 1977–1977. 3 indexed citations
9.
10.
11.
He, Zangdong, et al.. (2015). Simultaneous variable selection for joint models of longitudinal and survival outcomes. PMC.
12.
Tu, Wanzhu, Brian S. Decker, Zangdong He, et al.. (2015). Triamterene Enhances the Blood Pressure Lowering Effect of Hydrochlorothiazide in Patients with Hypertension. Journal of General Internal Medicine. 31(1). 30–36. 14 indexed citations
13.
Li, Yang, Kefu Tang, Zhao Zhang, et al.. (2010). Genetic diversity of the apolipoprotein E gene and diabetic nephropathy: a meta-analysis. Molecular Biology Reports. 38(5). 3243–3252. 25 indexed citations
14.
Zhang, Zhao, Klaus Lindpaintner, Ronglin Che, et al.. (2009). The Val/Met functional polymorphism in COMT confers susceptibility to bipolar disorder: evidence from an association study and a meta-analysis. Journal of Neural Transmission. 116(10). 1193–1200. 40 indexed citations
15.
Li, Zhiqiang, Zangdong He, Wei Tang, et al.. (2008). No genetic association between polymorphisms in the kainate-type glutamate receptor gene, GRIK4, and schizophrenia in the Chinese population. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 32(3). 876–880. 8 indexed citations
16.
Ma, Gang, Zangdong He, Wei Tang, et al.. (2008). The Ser9Gly polymorphism of the dopamine D3 receptor gene and risk of schizophrenia: An association study and a large meta-analysis. Schizophrenia Research. 101(1-3). 26–35. 17 indexed citations
17.
He, Zangdong, Ke Huang, Wei Tang, et al.. (2008). No genetic association between NCAM1 gene polymorphisms and schizophrenia in the Chinese population. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 32(7). 1633–1636. 9 indexed citations
18.
Meng, Junwei, Yongyong Shi, Xinzhi Zhao, et al.. (2007). No significant association between the genetic polymorphisms in the GSK-3β gene and schizophrenia in the Chinese population. Journal of Psychiatric Research. 42(5). 365–370. 14 indexed citations
19.
Ma, Gang, Yongyong Shi, Wei Tang, et al.. (2007). An association study between the genetic polymorphisms within TBX1 and schizophrenia in the Chinese population. Neuroscience Letters. 425(3). 146–150. 10 indexed citations
20.
He, Zangdong, Zhiqiang Li, Yongyong Shi, et al.. (2007). The PIP5K2A gene and schizophrenia in the Chinese population — A case-control study. Schizophrenia Research. 94(1-3). 359–365. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shipra Gandhi Breakdown of academic impact, for papers by Lu Zhao Breakdown of academic impact, for papers by Colin D. Godwin Breakdown of academic impact, for papers by Matts Kågedal Breakdown of academic impact, for papers by Shikiko Watanabe Breakdown of academic impact, for papers by Rosa Di Bitondo Breakdown of academic impact, for papers by A. Prechtl Breakdown of academic impact, for papers by David Ladkani Breakdown of academic impact, for papers by Martina Urbanek Breakdown of academic impact, for papers by Kevin Brady
Rankless by CCL
2026